Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Clinical evaluation of brief cognitive assessment measures for patients with severe dementia.

Dixon JS, Saddington DG, Shiles CJ, Sreevalsan KP, Munro CA, Rosenberg PB.

Int Psychogeriatr. 2017 Jul;29(7):1169-1174. doi: 10.1017/S1041610217000151. Epub 2017 Mar 29.

PMID:
28351445
2.

Prevalence of white spot lesions during orthodontic treatment with fixed appliances.

Tufekci E, Dixon JS, Gunsolley JC, Lindauer SJ.

Angle Orthod. 2011 Mar;81(2):206-10. doi: 10.2319/051710-262.1.

PMID:
21208070
3.

A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B : Lamivudine resistance.

Hann HW, Gregory VL, Dixon JS, Barker KF.

Hepatol Int. 2008 Dec;2(4):440-56. doi: 10.1007/s12072-008-9105-y. Epub 2008 Oct 21.

4.

Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008.

Michino M, Abola E; GPCR Dock 2008 participants, Brooks CL 3rd, Dixon JS, Moult J, Stevens RC.

Nat Rev Drug Discov. 2009 Jun;8(6):455-63. doi: 10.1038/nrd2877. Review.

5.

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J; Cirrhosis Asian Lamivudine Multicentre Study Group.

N Engl J Med. 2004 Oct 7;351(15):1521-31.

6.

Lamivudine facilitates optimal chemotherapy in hepatitis B virus-infected children with hematological malignancies: a preliminary report.

el-Sayed MH, Shanab G, Karim AM, el-Tawil A, Black A, Dixon JS.

Pediatr Hematol Oncol. 2004 Mar;21(2):145-56.

PMID:
15160513
7.

Antivirals for the treatment of chronic hepatitis B: current and future options.

Humphries JC, Dixon JS.

Intervirology. 2003;46(6):413-20.

PMID:
14688461
8.

Lamivudine for the treatment of chronic hepatitis B.

Dixon JS, Boehme RE.

Acta Gastroenterol Belg. 2000 Oct-Dec;63(4):348-56. Review.

PMID:
11233517
9.

Obstructive response of human bladder to BPH vs. rabbit bladder response to partial outlet obstruction: a direct comparison.

Levin RM, Haugaard N, O'Connor L, Buttyan R, Das A, Dixon JS, Gosling JA.

Neurourol Urodyn. 2000;19(5):609-29. No abstract available.

PMID:
11002303
10.

Correlation between the structure and function of the rabbit urinary bladder following partial outlet obstruction.

Gosling JA, Kung LS, Dixon JS, Horan P, Whitbeck C, Levin RM.

J Urol. 2000 Apr;163(4):1349-56.

PMID:
10737542
11.

DbetaH-immunoreactive subepithelial nerves in the vas deferens of prostate cancer patients.

Jen PY, Dixon JS.

J Anat. 2000 Jan;196 ( Pt 1):121. No abstract available.

15.

The distribution of noradrenergic nerves in the human lower urinary tract. A review.

Gosling JA, Dixon JS, Jen PY.

Eur Urol. 1999;36 Suppl 1:23-30. Review.

PMID:
10393469
16.

Feature trees: a new molecular similarity measure based on tree matching.

Rarey M, Dixon JS.

J Comput Aided Mol Des. 1998 Sep;12(5):471-90.

PMID:
9834908
17.

Structure and autonomic innervation of the human vas deferens: a review.

Dixon JS, Jen PY, Gosling JA.

Microsc Res Tech. 1998 Sep 15;42(6):423-32. Review.

PMID:
9817549
19.
20.

The structure and autonomic innervation of the vesico-ureteric junction in cases of primary ureteric reflux.

Dixon JS, Jen PY, Yeung CK, Chow LT, Mathews R, Gearhart JP, Gosling JA.

Br J Urol. 1998 Jan;81(1):146-51.

PMID:
9467492
21.

Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori.

Dixon JS, Pipkin GA, Mills JG, Wood JR.

J Physiol Pharmacol. 1997 Sep;48 Suppl 4:47-58. Review.

PMID:
9440055
22.

Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review.

Pipkin GA, Dixon JS, Williamson R, Wood JR.

Helicobacter. 1997 Dec;2(4):159-71. Review.

PMID:
9421117
24.

Evaluation of the CASP2 docking section.

Dixon JS.

Proteins. 1997;Suppl 1:198-204.

PMID:
9485512
25.
26.

The safety of ranitidine bismuth citrate in controlled clinical studies.

Pipkin GA, Mills JG, Kler L, Dixon JS, Wood JR.

Pharmacoepidemiol Drug Saf. 1996 Nov;5(6):399-407.

PMID:
15073811
27.

Review article: safety of bismuth in the treatment of gastrointestinal diseases.

Tillman LA, Drake FM, Dixon JS, Wood JR.

Aliment Pharmacol Ther. 1996 Aug;10(4):459-67. Review.

PMID:
8853750
28.
29.
30.
31.
32.

Flexible ligand docking using a genetic algorithm.

Oshiro CM, Kuntz ID, Dixon JS.

J Comput Aided Mol Des. 1995 Apr;9(2):113-30.

PMID:
7608743
33.

Development of peptide-containing nerves in the human fetal vas deferens and seminal vesicle.

Jen PY, Dixon JS, Gosling JA.

Br J Urol. 1995 Mar;75(3):378-85.

PMID:
7735805
34.

Immunohistochemical localization of neuromarkers and neuropeptides in human fetal and neonatal urinary bladder.

Jen PY, Dixon JS, Gosling JA.

Br J Urol. 1995 Feb;75(2):230-5. Erratum in: Br J Urol 1995 Apr;75(4):564.

PMID:
7531592
35.

Helicobacter pylori eradication: unravelling the facts.

Dixon JS.

Scand J Gastroenterol Suppl. 1995;212:48-62. Review.

PMID:
8578233
36.

A shape- and chemistry-based docking method and its use in the design of HIV-1 protease inhibitors.

DesJarlais RL, Dixon JS.

J Comput Aided Mol Des. 1994 Jun;8(3):231-42.

PMID:
7964924
37.

An immunohistochemical study of the innervation of the ureterovesical junction in infancy and childhood.

Dixon JS, Canning DA, Gearhart JP, Gosling JA.

Br J Urol. 1994 Mar;73(3):292-7.

PMID:
8162509
38.

Short report: long-term management of peptic ulcer disease with ranitidine in Germany.

Simon B, Schütz E, Müller P, Dixon JS.

Aliment Pharmacol Ther. 1994 Feb;8(1):135-7.

PMID:
8186340
39.

The effect of renal function on the pharmacokinetics of ranitidine.

Dixon JS, Borg-Costanzi JM, Langley SJ, Lacey LF, Toon S.

Eur J Clin Pharmacol. 1994;46(2):167-71.

PMID:
8039538
40.

The intramural innervation of the human vas deferens and seminal vesicle in infants and children.

Gosling JA, Dixon JS.

Scand J Urol Nephrol Suppl. 1994;157:75-81.

PMID:
7524144
41.

Association of age with the efficacy and safety of ranitidine and cimetidine in acute duodenal ulcer disease.

Dixon JS, Mills JG, Ehsanullah RS, Wood JR.

Age Ageing. 1993 Nov;22(6):411-8.

PMID:
8310886
42.

Early evening dosing of ranitidine. Comparison with nighttime dosing of ranitidine or cimetidine in duodenal ulceration.

Dixon JS, Ehsanullah RS, Mills JG, Wood JR.

Dig Dis Sci. 1993 Aug;38(8):1459-67.

PMID:
8344101
43.

A placebo-controlled investigation of duodenal ulcer recurrence after withdrawal of long-term treatment with ranitidine.

Penston JG, Dixon JS, Boyd EJ, Wormsley KG.

Aliment Pharmacol Ther. 1993 Jun;7(3):259-65.

PMID:
8364131
44.

Optimizing the assessment of disease activity during treatment with anti-rheumatoid drugs.

Astbury C, Platt R, Dixon JS, Le Gallez P, Hill J, Bird HA.

Br J Rheumatol. 1993 Jun;32(6):467-73.

PMID:
8099519
45.

Ultrastructural observations on cystitis cystica in human bladder urothelium.

Jost SP, Dixon JS, Gosling JA.

Br J Urol. 1993 Jan;71(1):28-33.

PMID:
8435733
46.

An immunohistochemical study of human postnatal paraganglia associated with the urinary bladder.

Dixon JS, Gosling JA, Canning DA, Gearhart JP.

J Anat. 1992 Dec;181 ( Pt 3):431-6.

47.

Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease.

Tomaszek TA Jr, Moore ML, Strickler JE, Sanchez RL, Dixon JS, Metcalf BW, Hassell A, Dreyer GB, Brooks I, Debouck C, et al.

Biochemistry. 1992 Oct 27;31(42):10153-68.

PMID:
1420138
48.

Increase in presumptive sensory nerves of the urinary bladder in idiopathic detrusor instability.

Moore KH, Gilpin SA, Dixon JS, Richmond DH, Sutherst JR.

Br J Urol. 1992 Oct;70(4):370-2.

PMID:
1450843
49.

Computer-aided drug design: getting the best results.

Dixon JS.

Trends Biotechnol. 1992 Oct;10(10):357-63.

PMID:
1368875
50.

Supplemental Content

Loading ...
Support Center